Search results for: 'digital therapeutics market size'

A digital twin is a virtual copy of a physical entity, which can be a product, system, component, or network of more complex systems. While a physical entity typically refers to tangible objects, a digital twin can also replicate a process, simulating and analyzing its performance. Thus, a digital twin can serve as a tool to virtually replicate and...

The global CGT therapeutics market is transitioning from a niche, high-complexity segment into a mainstream, high-growth therapeutic class. Driven by scientific breakthroughs, accelerated regulatory pathways, and the entry of next-generation platforms—including in vivo CRISPR gene editing, allogeneic “off-the-shelf” cell therapies, and automated sm...

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications. These biomarkers provide continuous, real-time insights into an individual’s health status and are used to monitor normal ...

The emergence of Industrial Internet of Things (IIoT) technologies is leading to increased adoption of smart sensors, intelligence field devices, intelligence I/O modules, wireless technologies, cloud computing, and smart mobility. With the growth of the IIoT and smart plant technologies, there will be a larger role for IT service providers to play...

A digital twin is a virtual replica of a product, system, or process. Geopolitical tensions arising as a result of the COVID-19 pandemic, trade disputes, wars between countries, and other factors have prompted automakers and their suppliers to employ digital technologies to minimize operational disruptions, reduce costs and resource utilization, re...

23 Aug 2019  |  Global  |  Market Outlook

Global Digital Health Outlook, 2020

Artificial Intelligence, Care Coordination, Cybersecurity, Data Analytics, Digital Therapeutics, and Telehealth Will Drive the Market

Infographics

×

This study predicts the ways that artificial intelligence, care coordination cybersecurity, data analytics, digital therapeutics, and telehealth will drive the digital health market in 2020. The report presents 9 predictions that are likely to prevail by 2020. Frost & Sullivan defines digital health as the application of data to the delivery of hea...

Although much of the focus on grid investment relates to hardware, there is a growing awareness of how important it is to increase the overall intelligence of the grid. Frost & Sullivan s Digital Grid Attractiveness Index analyzes and ranks countries based on how attractive they are for digital grid developments in terms of implementing improvement...

The pharmaceutical and biotechnology industries are entering a transformative era in 2025, shaped by a convergence of scientific innovation, regulatory evolution, and market pressures. One of the key imperatives is the continued advancement of therapeutics and drug approvals, as breakthrough treatments, particularly in personalized medicine, promis...

This study analyzes the emergence of engineered antibody therapeutics for cancer, examining the factors driving their adoption. The limitations of monoclonal antibodies have led to an increasing demand for novel formats. Companies are developing multispecific antibodies, such as bispecifics and trispecifics, and antibody fragments, such as Fab and ...